🇺🇸 FDA
Patent

US 7304071

Protein kinase inhibitors and uses thereof

granted A61PA61P1/04A61P1/16

Quick answer

US patent 7304071 (Protein kinase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P1/04, A61P1/16, A61P1/18, A61P11/00